Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 5374931, 12 pages
http://dx.doi.org/10.1155/2016/5374931
Research Article

Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens

1School of Pharmacy, West Virginia University, Morgantown, WV, USA
2Sanofi US, Inc., Bridgewater, NJ, USA

Received 4 April 2016; Revised 19 August 2016; Accepted 29 August 2016

Academic Editor: Brunella Capaldo

Copyright © 2016 Usha Sambamoorthi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Monnier and C. Colette, “Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities,” Diabetes and Metabolism, vol. 32, no. 1, pp. 7–13, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Raccah, “Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus,” Diabetes, Obesity and Metabolism, vol. 10, no. 2, pp. 76–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. E. Inzucchi, R. M. Bergenstal, J. B. Buse et al., “Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes,” Diabetes Care, vol. 38, no. 1, pp. 140–149, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Subramanian and I. B. Hirsch, “Personalized diabetes management: moving from algorithmic to individualized therapy,” Diabetes Spectrum, vol. 27, no. 2, pp. 87–91, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. Riddle, “The transition from oral agents to combination insulin/oral therapy,” in Contemporary Endocrinology: Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management, M. N. Feinglos and M. A. Bethel, Eds., pp. 169–181, Humana Press, Totowa, NJ, USA, 2008. View at Google Scholar
  6. S. Kokić, D. Buković, M. Radman et al., “Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure,” Collegium Antropologicum, vol. 27, no. 1, pp. 181–187, 2003. View at Google Scholar · View at Scopus
  7. L. Pala, E. Mannucci, I. Dicembrini, and C. M. Rotella, “A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients,” Diabetes Research and Clinical Practice, vol. 78, no. 1, pp. 132–135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Rosenstock, B. Zinman, L. J. Murphy et al., “Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial,” Annals of Internal Medicine, vol. 143, no. 8, pp. 549–558, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. M. Bonafede, A. Kalsekar, M. Pawaskar et al., “Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis,” BMC Endocrine Disorders, vol. 11, article 3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Centers for Disease Control and Prevention, National Diabetes Statistics Report, 2014: Estimates of Diabetes and Its Burden in the United States, Centers for Disease Control and Prevention, Atlanta, Ga, USA, 2014, http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf.
  11. K. M. V. Narayan, J. P. Boyle, L. S. Geiss, J. B. Saaddine, and T. J. Thompson, “Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050,” Diabetes Care, vol. 29, no. 9, pp. 2114–2116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. E. S. Huang, A. Basu, M. O'Grady, and J. C. Capretta, “Projecting the future diabetes population size and related costs for the U.S.,” Diabetes Care, vol. 32, no. 12, pp. 2225–2229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. A. Ginde, P. G. Blanc, R. M. Lieberman, and C. A. Camargo Jr., “Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits,” BMC Endocrine Disorders, vol. 8, article 4, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. H.-Y. Chang, J. P. Weiner, T. M. Richards, S. N. Bleich, and J. B. Segal, “Validating the adapted diabetes complications severity index in claims data,” American Journal of Managed Care, vol. 18, no. 11, pp. 721–726, 2012. View at Google Scholar · View at Scopus
  15. E. Ickowicz, “Guidelines for improving the care of the older person with diabetes mellitus,” Journal of the American Geriatrics Society, vol. 51, no. 5, pp. S265–S280, 2003. View at Google Scholar · View at Scopus
  16. S. Mehta, H. Chen, M. L. Johnson, and R. R. Aparasu, “Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort study,” Drugs & Aging, vol. 27, no. 10, pp. 815–829, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. E. Tinetti, C. Gordon, E. Sogolow, P. Lapin, and E. H. Bradley, “Fall-risk evaluation and management: challenges in adopting geriatric care practices,” Gerontologist, vol. 46, no. 6, pp. 717–725, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. T. Anger, C. S. Saigal, R. Madison, G. Joyce, M. S. Litwin, and Urologic Diseases of America Project, “Increasing costs of urinary incontinence among female medicare beneficiaries,” The Journal of Urology, vol. 176, no. 1, pp. 247–251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. F. Goldberg, J. O. Brooks III, K. Kurita et al., “Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD,” Journal of Clinical Psychiatry, vol. 70, no. 2, pp. 155–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Sorli and M. K. Heile, “Identifying and meeting the challenges of insulin therapy in type 2 diabetes,” Journal of Multidisciplinary Healthcare, vol. 7, pp. 267–282, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Monnier, H. Lapinski, and C. Colette, “Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c,” Diabetes Care, vol. 26, no. 3, pp. 881–885, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. M. J. Davies, J. J. Gagliardino, L. J. Gray, K. Khunti, V. Mohan, and R. Hughes, “Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review,” Diabetic Medicine, vol. 30, no. 5, pp. 512–524, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Janes, J. Titchener, J. Pere, R. Pere, and J. Senior, “Understanding barriers to glycaemic control from the patient's perspective,” Journal of Primary Health Care, vol. 5, no. 2, pp. 114–122, 2013. View at Google Scholar · View at Scopus
  24. S. Nam, C. Chesla, N. A. Stotts, L. Kroon, and S. L. Janson, “Barriers to diabetes management: patient and provider factors,” Diabetes Research and Clinical Practice, vol. 93, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus